Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Defense
Grant: W81XWH-17-TSCRP-CTRA
National Cancer Institute
Grant: CCSG P30 CA060553
National Cancer Institute
Grant: CA060553
National Science Foundation
Grant: ECCS-1542205
National Cancer Institute
Grant: P30-CA060553
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Science Foundation
Grant: 1542205
NNCI: Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource
National Institutes of Health
Grant: 1P30AR075049-01
Northwestern University Skin Biology and Diseases Resource-based Center
National Institutes of Health
Grant: 5R01CA191317-05
Separating autoimmunity and anti-tumor immunity
Fields of Study
Keywords
Sustainable Development Goals